Note: These are based on policies enacted after the COVID-19 public health emergency was declared in January 2020 and are subject to change.
1. On Jan. 1, CMS will stop handing out $40 reimbursements for every COVID-19 vaccine administered by pharmacists. The payment will align with the rate set by other Part B vaccines. Free vaccine jabs for the public will also end. Moderna and Pfizer have tentatively said they plan to sell their shots for up to $130 each.
2. COVID-19 treatments such as Paxlovid will no longer be free for patients at the end of PHE.
3. CMS will stop covering up to eight COVID-19 at-home tests.
4. States and private insurance companies have the option to continue covering pharmacist-provided services, including COVID-19 testing, but there will no longer be a federal requirement to do so.
5. During the PHE, clinicians registered with the Drug Enforcement Administration have been able to prescribe schedule II-V controlled substances to patients they have not seen in person but with whom they have done a telehealth visit. This will expire.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
